VERDICT
Scientific editing, translation, and journal selection services for researchers. - edanz.com
Depends. Buy if you are a non-native-English researcher with a manuscript near submission who wants human editors and journal-matching help. Skip it if you expected software pricing, a self-serve tool, or any acceptance guarantee.
Medium. Based on 13 public sources; no public pricing tiers or customer rating numbers found, so stats omitted and scores marked null where unevidenced.
Not disclosed
medium
Custom per-manuscript quotes; costs can balloon on long papers
medium
Editing certificates cover language only; no acceptance guarantee
medium
Journal selector output lacks validation; verify matches yourself
low
Name collides with unrelated EDANZ groups; verify you're on
Feature depth: 4/5
Rating
Not disclosed
Starting price
13
Sources
Analyzed
Not disclosed
No known vulnerabilities found in the sources reviewed.
Customer reviews are scarce; the most visible reviews are from employees, split between 'flexible hours, low-stress' and severe overwork complaints.
“Edanz - They are working me to death”
“Flexible hours, low-stress,”
“It is a sink”
Compare Edanz with each alternative.
Same group per Manusights; large editor pool, per-word pricing
Competing editing service compared head-to-head with Edanz
Free journal/author name matcher; no editing included
Free journal matching; skip paid selection services
Based on 13 public sources; no public pricing tiers or customer rating numbers found, so stats omitted and scores marked null where unevidenced.
Human editing + journal selection for researchers. Legit but quote-based pricing; wrong buy if you wanted software or guaranteed acceptance.
Based on 13 public sources; no public pricing tiers or customer rating numbers found, so stats omitted and scores marked null where unevidenced.
Anonymous. You can change your vote.
Loading votes…
Comments
One queue. No nested comments. Give a display name first. Limit: 200 words per comment and 7 comments per day. You can edit or delete yours.
No comments yet.